Mustang Bio Statistics
Total Valuation
Mustang Bio has a market cap or net worth of $9.48 million. The enterprise value is -$3.10 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Mustang Bio has 7.24 million shares outstanding. The number of shares has increased by 750.59% in one year.
| Current Share Class | 6.39M |
| Shares Outstanding | 7.24M |
| Shares Change (YoY) | +750.59% |
| Shares Change (QoQ) | +40.56% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 3.65% |
| Float | 6.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.00 |
| P/TBV Ratio | 3.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.30
| Current Ratio | 1.30 |
| Quick Ratio | 1.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -513.80 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -14.89% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -84.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$546,167 |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.69% in the last 52 weeks. The beta is 2.10, so Mustang Bio's price volatility has been higher than the market average.
| Beta (5Y) | 2.10 |
| 52-Week Price Change | -89.69% |
| 50-Day Moving Average | 1.54 |
| 200-Day Moving Average | 1.75 |
| Relative Strength Index (RSI) | 36.31 |
| Average Volume (20 Days) | 111,046 |
Short Selling Information
The latest short interest is 68,415, so 0.95% of the outstanding shares have been sold short.
| Short Interest | 68,415 |
| Short Previous Month | 60,750 |
| Short % of Shares Out | 0.95% |
| Short % of Float | 1.12% |
| Short Ratio (days to cover) | 0.56 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.57M |
| Pretax Income | -3.28M |
| Net Income | -3.28M |
| EBITDA | -2.43M |
| EBIT | -2.57M |
| Earnings Per Share (EPS) | -$1.51 |
Full Income StatementBalance Sheet
The company has $12.66 million in cash and n/a in debt, giving a net cash position of $12.66 million or $1.75 per share.
| Cash & Cash Equivalents | 12.66M |
| Total Debt | n/a |
| Net Cash | 12.66M |
| Net Cash Per Share | $1.75 |
| Equity (Book Value) | 2.89M |
| Book Value Per Share | 0.66 |
| Working Capital | 3.04M |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.48M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.48M |
| FCF Per Share | -$0.90 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
